UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy

Oncogene, 2015-04, Vol.34 (15), p.1919-1927

2015

Volltextzugriff (PDF)

Rates of re‐excision and conversion to mastectomy after breast‐conserving surgery with or without oncoplastic surgery: a nationwide population‐based study

British journal of surgery, 2020-12, Vol.107 (13), p.1762-1772

2020

Volltextzugriff (PDF)

Correction: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy

Oncogene, 2020-03, Vol.39 (10), p.2229-2230

2020

Volltextzugriff (PDF)

Correction: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy

Oncogene, 2018-10, Vol.37 (41), p.5585-5586

2018

Volltextzugriff (PDF)

A kinase inhibitor screen identifies Mcl-1 and Aurora kinase A as novel treatment targets in antiestrogen-resistant breast cancer cells

Oncogene, 2015-08, Vol.34 (32), p.4199-4210

2015

Volltextzugriff (PDF)

PIK3CA mutations, PTEN, and pHER2 expression and impact on outcome in HER2-positive early-stage breast cancer patients treated with adjuvant chemotherapy and trastuzumab

Annals of oncology, 2012-08, Vol.23 (8), p.2034-2042

2012

Volltextzugriff (PDF)

Breast cancer after bilateral risk-reducing mastectomy

Clinical genetics, 2011-05, Vol.79 (5), p.431-437

2011

Volltextzugriff (PDF)

OP0026 Gene expression profiling identifies FYN as important in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy

European journal of cancer (1990), 2014-05, Vol.50, p.e9-e10

2014

Volltextzugriff (PDF)

Independent prognostic value of angiogenesis and the level of plasminogen activator inhibitor type 1 in breast cancer patients

British journal of cancer, 2003-01, Vol.88 (1), p.102-108

2003

Volltextzugriff (PDF)

Prognostic significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in primary breast cancer

British journal of cancer, 1998-03, Vol.77 (6), p.932-940

1998

Volltextzugriff (PDF)

24P Consensus on the utility of breast cancer multigene signatures in routine clinical practice among European breast cancer clinicians: The PROCURE project

Annals of oncology, 2021-05, Vol.32, p.S30-S31

2021

Volltextzugriff (PDF)

Evaluation of tumor-infiltrating lymphocytes and association with prognosis in BRCA-mutated breast cancer

Acta oncologica, 2019-03, Vol.58 (3), p.363-370

2019

Volltextzugriff (PDF)

P239 - Prognostic and predictive impact of estrogen receptor alpha gene (ESR1) expression in postmenopausal women with early breast cancer: Results from the DBCG 77C trial

Breast (Edinburgh), 2019-03, Vol.44, p.S98-S98

2019

Volltextzugriff (PDF)

Prognostic and predictive impact of estrogen receptor alpha gene (ESR1) expression in postmenopausal women with early breast cancer: Results from the DBCG 77C trial

Breast (Edinburgh), 2019-03, Vol.44, p.S98

2019

Volltextzugriff (PDF)

Clinical and molecular characterization of BRCA-associated breast cancer: results from the DBCG

Acta oncologica, 2018-01, Vol.57 (1), p.95-101

2018

Volltextzugriff (PDF)

Abstract P6-02-11: When needles are needed

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P6-P6-02-11

2016

Volltextzugriff (PDF)

Abstract P2-10-02: Basal biomarkers nestin and INPP4b predict gemcitabine benefit in metastatic breast cancer: Results from the phase III SBG0102 clinical trial

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P2-P2-10-02

2018

Volltextzugriff (PDF)

Abstract P2-03-01: Analytical validation of a standardized scoring protocol for Ki67 assessed on breast excision whole sections: An international multicenter collaboration

Cancer research (Chicago, Ill.), 2018, Vol.78 (4_Supplement), p.P2-P2-03-01

2018

Volltextzugriff (PDF)

Independent prognostic value of angiogenesis and the level of plasminogen activator inhibitor type I in breast cancer patients

British journal of cancer, 2003-01, Vol.88 (1), p.102-108

2003

Volltextzugriff (PDF)

Abstract P1-13-03: ER, PR, HER2, and Ki67 index and responsiveness to adjuvant tamoxifen in postmenopausal high-risk breast cancer patients enrolled in the DBCG 77C trial

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P1-P1-13-03

2013

Volltextzugriff (PDF)

P9 Altered expression of plasma membrane proteins on breast cancer cells capable of forming metastasis. Identification by comparative proteomic analysis

European journal of cancer supplements, 2007, Vol.5 (8), p.27-27

2007

Volltextzugriff (PDF)

Abstract P4-09-04: Gene expression profile that predict outcome of Tamoxifen-treated estrogen receptor-positive, high-risk, primary breast cancer patients: a DBCG study

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.P4-P4-09-04

2012

Volltextzugriff (PDF)

Abstract P1-01-01: Analytical validation of a standardized scoring protocol for Ki67: Phase-3 of an international multicenter collaboration

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P1-P1-01-01

2016

Volltextzugriff (PDF)

Abstract P4-08-01: ESR1 Gene Aberrations Correlate with ER Protein Levels Measured by DCC and IHC

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.P4-P4-08-01

2010

Volltextzugriff (PDF)

164P Current use of breast cancer multigene signatures in clinical practice among European experts: Results from the PROCURE Project

Annals of oncology, 2022-09, Vol.33, p.S613

2022

Volltextzugriff (PDF)

1 – 25 von 54

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(51)

Publikationsform

Artikel
(53)
Tagungsberichte
(1)

Sprache

Englisch
(54)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy

Rates of re‐excision and conversion to mastectomy after breast‐conserving surgery with or without oncoplastic surgery: a nationwide population‐based study

Correction: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy

Correction: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy

A kinase inhibitor screen identifies Mcl-1 and Aurora kinase A as novel treatment targets in antiestrogen-resistant breast cancer cells

PIK3CA mutations, PTEN, and pHER2 expression and impact on outcome in HER2-positive early-stage breast cancer patients treated with adjuvant chemotherapy and trastuzumab

Breast cancer after bilateral risk-reducing mastectomy

OP0026 Gene expression profiling identifies FYN as important in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy

Independent prognostic value of angiogenesis and the level of plasminogen activator inhibitor type 1 in breast cancer patients

Prognostic significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in primary breast cancer

24P Consensus on the utility of breast cancer multigene signatures in routine clinical practice among European breast cancer clinicians: The PROCURE project

Evaluation of tumor-infiltrating lymphocytes and association with prognosis in BRCA-mutated breast cancer

P239 - Prognostic and predictive impact of estrogen receptor alpha gene (ESR1) expression in postmenopausal women with early breast cancer: Results from the DBCG 77C trial

Prognostic and predictive impact of estrogen receptor alpha gene (ESR1) expression in postmenopausal women with early breast cancer: Results from the DBCG 77C trial

Clinical and molecular characterization of BRCA-associated breast cancer: results from the DBCG

Abstract P6-02-11: When needles are needed

Abstract P2-10-02: Basal biomarkers nestin and INPP4b predict gemcitabine benefit in metastatic breast cancer: Results from the phase III SBG0102 clinical trial

Abstract P2-03-01: Analytical validation of a standardized scoring protocol for Ki67 assessed on breast excision whole sections: An international multicenter collaboration

Independent prognostic value of angiogenesis and the level of plasminogen activator inhibitor type I in breast cancer patients

Abstract P1-13-03: ER, PR, HER2, and Ki67 index and responsiveness to adjuvant tamoxifen in postmenopausal high-risk breast cancer patients enrolled in the DBCG 77C trial

P9 Altered expression of plasma membrane proteins on breast cancer cells capable of forming metastasis. Identification by comparative proteomic analysis

Abstract P4-09-04: Gene expression profile that predict outcome of Tamoxifen-treated estrogen receptor-positive, high-risk, primary breast cancer patients: a DBCG study

Abstract P1-01-01: Analytical validation of a standardized scoring protocol for Ki67: Phase-3 of an international multicenter collaboration

Abstract P4-08-01: ESR1 Gene Aberrations Correlate with ER Protein Levels Measured by DCC and IHC

164P Current use of breast cancer multigene signatures in clinical practice among European experts: Results from the PROCURE Project

Suchergebnisse filtern